Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity

M.H. Vingerhoeds, H.J. Haisma, S.O. Belliot, R.H.P. Smit, D.J.A. Crommelin, G. Storm

    Research output: Contribution to journalArticleAcademicpeer-review

    44 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)604-610
    JournalPharmaceutical Research
    Publication statusPublished - 1996


    • ADEPT
    • Antibody-directed enzyme prodrug therapy
    • Liposomes
    • Monoclonal antibody
    • Targeted drug delivery

    Cite this